Everence Capital Management’s Elevance Health ELV Stock Holding History

Everence Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.41M	Sell	4,820 -464	-9%	-$152K	0.09%	191
2025 Q4	$1.85M	Sell	5,284 -1,138	-18%	-$385K	0.11%	147
2025 Q3	$2.08M	Sell	6,422 -958	-13%	-$298K	0.12%	136
2025 Q2	$2.87M	Sell	7,380 -660	-8%	-$265K	0.18%	102
2025 Q1	$3.5M	Buy	8,040 +530	+7%	+$213K	0.24%	83
2024 Q4	$2.77M	Sell	7,510 -1,500	-17%	-$628K	0.18%	94
2024 Q3	$4.68M	Hold	9,010	–	–	0.3%	57
2024 Q2	$4.76K	Hold	9,010	–	–	0.33%	50
2024 Q1	$4.67K	Hold	9,010	–	–	0.31%	56
2023 Q4	$4.25M	Buy	9,010 +2,210	+33%	+$1.02M	0.3%	61
2023 Q3	$2.96K	Buy	6,800 +890	+15%	+$404K	0.23%	85
2023 Q2	$2.65M	Hold	5,910	–	–	0.22%	90
2023 Q1	$2.72K	Sell	5,910 -1,600	-21%	-$761K	0.22%	91
2022 Q4	$3.85K	Buy	7,510 +190	+3%	+$96.5K	0.33%	53
2022 Q3	$3.33M	Hold	7,320	–	–	0.31%	62
2022 Q2	$3.53M	Hold	7,320	–	–	0.32%	64
2022 Q1	$3.6M	Hold	7,320	–	–	0.28%	75
2021 Q4	$3.39M	Hold	7,320	–	–	0.25%	67
2021 Q3	$2.73M	Hold	7,320	–	–	0.22%	80
2021 Q2	$2.79M	Hold	7,320	–	–	0.23%	81
2021 Q1	$2.63M	Buy	7,320 +370	+5%	+$119K	0.24%	73
2020 Q4	$2.23M	Buy	6,950 +930	+15%	+$285K	0.22%	76
2020 Q3	$1.62M	Hold	6,020	–	–	0.18%	104
2020 Q2	$1.77M	Hold	6,020	–	–	0.21%	88
2020 Q1	$1.37M	Hold	6,020	–	–	0.19%	91
2019 Q4	$1.82M	Buy	6,020 +830	+16%	+$228K	0.27%	75
2019 Q3	$1.25M	Hold	5,190	–	–	0.2%	111
2019 Q2	$1.47M	Hold	5,190	–	–	0.24%	96
2019 Q1	$1.49M	Sell	5,190 -1,431	-22%	-$414K	0.26%	91
2018 Q4	$1.74M	Buy	6,621 +670	+11%	+$184K	0.4%	66
2018 Q3	$1.63M	Hold	5,951	–	–	0.32%	74
2018 Q2	$1.42M	Hold	5,951	–	–	0.3%	79
2018 Q1	$1.31M	Hold	5,951	–	–	0.29%	86
2017 Q4	$1.34M	Buy	5,951 +481	+9%	+$102K	0.29%	86
2017 Q3	$1.04M	Hold	5,470	–	–	0.24%	123
2017 Q2	$1.03M	Hold	5,470	–	–	0.25%	114
2017 Q1	$905K	Hold	5,470	–	–	0.24%	119
2016 Q4	$786K	Buy	5,470 +1,170	+27%	+$157K	0.23%	128
2016 Q3	$539K	Hold	4,300	–	–	0.16%	180
2016 Q2	$565K	Buy	+4,300	New	+$588K	0.17%	172
2015 Q4	–	Sell	-5,655	Closed	-$792K	–	300
2015 Q3	$792K	Hold	5,655	–	–	0.27%	109
2015 Q2	$928K	Hold	5,655	–	–	0.3%	102
2015 Q1	$828K	Hold	5,655	–	–	0.28%	112
2014 Q4	$711K	Hold	5,655	–	–	0.24%	123
2014 Q3	$659K	Hold	5,655	–	–	0.24%	135
2014 Q2	$609K	Hold	5,655	–	–	0.23%	140
2014 Q1	$563K	Hold	5,655	–	–	0.22%	141
2013 Q4	$522K	Sell	5,655 -1,290	-19%	-$115K	0.21%	147
2013 Q3	$581K	Hold	6,945	–	–	0.25%	121
2013 Q2	$568K	Buy	+6,945	New	+$520K	0.26%	112

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Everence Capital Management's ELV Position: Q1 2026 in Review

Everence Capital Management reduced its Elevance Health (ELV) stake by 8.8% in Q1 2026, selling an estimated $152K and leaving 4,820 shares worth $1.41M. The position accounts for 0.09% of the portfolio, ranked #191.

Everence Capital Management first reported a position in ELV in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.68M in Q3 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Everence Capital Management held 4,820 shares of Elevance Health worth $1.41M as of Q1 2026.
Everence Capital Management sold 464 Elevance Health shares in Q1 2026, an estimated $152K.
Elevance Health made up 0.09% of Everence Capital Management's portfolio in Q1 2026, its #191 holding.
Everence Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 50 quarters since.
Everence Capital Management's Elevance Health position peaked at $4.68M in Q3 2024.
1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.